4/A

OWNERSHIP DOCUMENT

Company: Ernexa Therapeutics Inc.
Filed: June 24, 2015
Period of Report: May 15, 2015
Accession Number: 0001019687-15-002507

View Document ↗ View on SEC.gov ↗